Emerging therapies in primary sclerosing cholangitis: pathophysiological basis and clinical opportunities
出版年份 2020 全文链接
标题
Emerging therapies in primary sclerosing cholangitis: pathophysiological basis and clinical opportunities
作者
关键词
-
出版物
JOURNAL OF GASTROENTEROLOGY
Volume 55, Issue 6, Pages 588-614
出版商
Springer Science and Business Media LLC
发表日期
2020-03-28
DOI
10.1007/s00535-020-01681-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis
- (2020) C.R.H. Hedin et al. Clinical Gastroenterology and Hepatology
- A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis
- (2020) Kris V. Kowdley et al. JOURNAL OF HEPATOLOGY
- The nonsteroidal FXR agonist cilofexor (GS-9674) improves markers of cholestasis and liver injury in patients with PSC
- (2019) Michael Trauner et al. HEPATOLOGY
- Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis
- (2019) Nobuhiro Nakamoto et al. Nature Microbiology
- Cholangiocyte pathobiology
- (2019) Jesus M. Banales et al. Nature Reviews Gastroenterology & Hepatology
- Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis
- (2019) Lijun Liao et al. GUT
- Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis
- (2019) Jessica R. Allegretti et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Effects of Vedolizumab in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases
- (2019) Kate D. Lynch et al. Clinical Gastroenterology and Hepatology
- Emerging roles of bile acids in mucosal immunity and inflammation
- (2019) Mei Lan Chen et al. Mucosal Immunology
- A network meta-analysis of randomized controlled trials exploring the role of fecal microbiota transplantation in recurrent Clostridium difficile infection
- (2019) Theodore Rokkas et al. United European Gastroenterology Journal
- Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis
- (2019) Malte Rühlemann et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- AGA Institute Clinical Practice Update: Surveillance for Hepatobiliary Cancers in Patients with Primary Sclerosing Cholangitis
- (2019) Christopher L. Bowlus et al. Clinical Gastroenterology and Hepatology
- Fecal Microbial Transplantation for Diseases Beyond Recurrent Clostridium Difficile Infection
- (2019) Geert R. D’Haens et al. GASTROENTEROLOGY
- Alterations of the bile microbiome in primary sclerosing cholangitis
- (2019) Timur Liwinski et al. GUT
- Validation, Clinical Utility and Limitations of the Amsterdam-Oxford Model for Primary Sclerosing Cholangitis
- (2019) Jorn C. Goet et al. JOURNAL OF HEPATOLOGY
- Pathogenesis, diagnosis and treatment of premalignant and malignant stages of cholangiocarcinoma in primary sclerosing cholangitis
- (2019) Marit Maehle Grimsrud et al. LIVER INTERNATIONAL
- Effects of Antibiotic Therapy in Primary Sclerosing Cholangitis with and without Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
- (2019) Ayesha Shah et al. SEMINARS IN LIVER DISEASE
- Gut microbiota in PSC : From association to possible causality. Commentary to “Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis” by Nakamoto et al., Nature Microbiology, January 2019
- (2019) Sara Lemoinne et al. Clinics and Research in Hepatology and Gastroenterology
- Autotaxin activity predicts transplant-free survival in primary sclerosing cholangitis
- (2019) Amandeep K. Dhillon et al. Scientific Reports
- Quantitative microbiome profiling disentangles inflammation- and bile duct obstruction-associated microbiota alterations across PSC/IBD diagnoses
- (2019) Sara Vieira-Silva et al. Nature Microbiology
- Long-term efficacy and safety of obeticholic acid for patients with primary biliary cholangitis: 3-year results of an international open-label extension study
- (2019) Michael Trauner et al. Lancet Gastroenterology & Hepatology
- The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications
- (2019) Jessica R Allegretti et al. LANCET
- Bile acid metabolites control TH17 and Treg cell differentiation
- (2019) Saiyu Hang et al. NATURE
- Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease
- (2019) Yi Duan et al. NATURE
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
- (2019) Zobair M Younossi et al. LANCET
- T cell receptor cross-reactivity between gliadin and bacterial peptides in celiac disease
- (2019) Jan Petersen et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease
- (2018) B. Christensen et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Serological markers of extracellular matrix remodeling predict transplant-free survival in primary sclerosing cholangitis
- (2018) M. J. Nielsen et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Review article: the evidence that vancomycin is a therapeutic option for primary sclerosing cholangitis
- (2018) J. L. Damman et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium
- (2018) Mario Strazzabosco et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma
- (2018) Brian K. Chung et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Colesevelam attenuates cholestatic liver and bile duct injury inMdr2−/−mice by modulating composition, signalling and excretion of faecal bile acids
- (2018) Claudia Daniela Fuchs et al. GUT
- Design and Endpoints for Clinical Trials in Primary Sclerosing Cholangitis
- (2018) Cyriel Y. Ponsioen et al. HEPATOLOGY
- Primary Sclerosing Cholangitis Risk Estimate Tool (PREsTo) Predicts Outcomes in PSC: A Derivation & Validation Study Using Machine Learning
- (2018) John E. Eaton et al. HEPATOLOGY
- A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis
- (2018) Scott L. Friedman et al. HEPATOLOGY
- Surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis
- (2018) Ahmad Hassan Ali et al. HEPATOLOGY
- Lysyl oxidase-like protein 2 (LOXL2) modulates barrier function in cholangiocytes in cholestasis
- (2018) Marion J. Pollheimer et al. JOURNAL OF HEPATOLOGY
- A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis
- (2018) Christophe Corpechot et al. NEW ENGLAND JOURNAL OF MEDICINE
- Simtuzumab for Primary Sclerosing Cholangitis: Phase 2 Study Results With Insights on the Natural History of the Disease
- (2018) Andrew J. Muir et al. HEPATOLOGY
- Circulating markers of gut barrier function associated with disease severity in primary sclerosing cholangitis
- (2018) Amandeep K Dhillon et al. LIVER INTERNATIONAL
- Primary sclerosing cholangitis response to the combination of fibrates with ursodeoxycholic acid: French–Spanish experience
- (2018) Sara Lemoinne et al. Clinics and Research in Hepatology and Gastroenterology
- Oral Abstracts (Abstracts 1-299)
- (2018) HEPATOLOGY
- Factors Associated With Outcomes of Patients With Primary Sclerosing Cholangitis and Development and Validation of a Risk Scoring System
- (2018) E C Goode et al. HEPATOLOGY
- Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial
- (2018) Gideon M. Hirschfield et al. JOURNAL OF HEPATOLOGY
- Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline
- (2017) Lars Aabakken et al. ENDOSCOPY
- Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis
- (2017) Tobias J. Weismüller et al. GASTROENTEROLOGY
- A novel prognostic model for transplant-free survival in primary sclerosing cholangitis
- (2017) Elisabeth M de Vries et al. GUT
- Cholangiocytes and the environment in primary sclerosing cholangitis: where is the link?
- (2017) Steven P O’Hara et al. GUT
- Vascular adhesion protein-1 is elevated in primary sclerosing cholangitis, is predictive of clinical outcome and facilitates recruitment of gut-tropic lymphocytes to liver in a substrate-dependent manner
- (2017) Palak J Trivedi et al. GUT
- Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal
- (2017) Naoki Ikenaga et al. GUT
- Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: An international cohort study
- (2017) Elisabeth M. G. de Vries et al. HEPATOLOGY
- New therapeutic concepts in bile acid transport and signaling for management of cholestasis
- (2017) Michael Trauner et al. HEPATOLOGY
- Enteric microbiome profiles during a randomized Phase 2 clinical trial of surotomycin versus vancomycin for the treatment of Clostridium difficile infection
- (2017) Kristine Cannon et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Combination Therapy of All-Trans Retinoic Acid With Ursodeoxycholic Acid in Patients With Primary Sclerosing Cholangitis
- (2017) David N. Assis et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- No negative impact of serum IgG4 levels on clinical outcome in 435 patients with primary sclerosing cholangitis from Japan
- (2017) Atsushi Tanaka et al. Journal of Hepato-Biliary-Pancreatic Sciences
- EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis
- (2017) Gideon M. Hirschfield et al. JOURNAL OF HEPATOLOGY
- nor Ursodeoxycholic acid improves cholestasis in primary sclerosing cholangitis
- (2017) Peter Fickert et al. JOURNAL OF HEPATOLOGY
- Primary sclerosing cholangitis – a comprehensive review
- (2017) Tom H. Karlsen et al. JOURNAL OF HEPATOLOGY
- Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis
- (2017) Mette Vesterhus et al. JOURNAL OF HEPATOLOGY
- Discovery of Tropifexor (LJN452), a Highly Potent Non-bile Acid FXR Agonist for the Treatment of Cholestatic Liver Diseases and Nonalcoholic Steatohepatitis (NASH)
- (2017) David C. Tully et al. JOURNAL OF MEDICINAL CHEMISTRY
- Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multi-centre study
- (2017) Elisabeth M.G. de Vries et al. LIVER INTERNATIONAL
- Genetics of primary sclerosing cholangitis and pathophysiological implications
- (2017) Xiaojun Jiang et al. Nature Reviews Gastroenterology & Hepatology
- The Microbiome in Primary Sclerosing Cholangitis: Current Evidence and Potential Concepts
- (2017) Johannes Hov et al. SEMINARS IN LIVER DISEASE
- Fibrates for the treatment of cholestatic itch (FITCH): study protocol for a randomized controlled trial
- (2017) Ruth Bolier et al. Trials
- Non-cell-autonomous activation of IL-6/STAT3 signaling mediates FGF19-driven hepatocarcinogenesis
- (2017) Mei Zhou et al. Nature Communications
- Primary sclerosing cholangitis: 50 years of a gut–liver relationship and still no love?
- (2016) Tom H Karlsen GUT
- The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls
- (2016) Martin Kummen et al. GUT
- Performance of magnetic resonance elastography in primary sclerosing cholangitis
- (2016) John E Eaton et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- A triple blinded, randomized, placebo-controlled clinical trial to evaluate the efficacy and safety of oral vancomycin in primary sclerosing cholangitis: a pilot study
- (2016) Journal of Gastrointestinal and Liver Diseases
- Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis
- (2016) Anna Baghdasaryan et al. JOURNAL OF HEPATOLOGY
- Alkaline phosphatase at diagnosis of primary sclerosing cholangitis and 1 year later: evaluation of prognostic value
- (2016) Elisabeth M. G. de Vries et al. LIVER INTERNATIONAL
- Evaluation of Biliary Calprotectin as a Biomarker in Primary Sclerosing Cholangitis
- (2016) Annika Gauss et al. MEDICINE
- Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease
- (2016) Sun-Gou Ji et al. NATURE GENETICS
- Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci
- (2016) David Ellinghaus et al. NATURE GENETICS
- Primary Sclerosing Cholangitis
- (2016) Konstantinos N. Lazaridis et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
- (2016) Frederik Nevens et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis
- (2016) Natalia Gomez-Ospina et al. Nature Communications
- Serum Autotaxin is a Marker of the Severity of Liver Injury and Overall Survival in Patients with Cholestatic Liver Diseases
- (2016) Ewa Wunsch et al. Scientific Reports
- Validation of Transient Elastography and Comparison with Spleen Length Measurement for Staging of Fibrosis and Clinical Prognosis in Primary Sclerosing Cholangitis
- (2016) Hanno Ehlken et al. PLoS One
- Impaired Hepatic Adaptation to Chronic Cholestasis induced by Primary Sclerosing Cholangitis
- (2016) Malgorzata Milkiewicz et al. Scientific Reports
- Therapy of Primary Sclerosing Cholangitis - Today and Tomorrow
- (2015) Emina Halilbasic et al. DIGESTIVE DISEASES
- Pharmacological inhibition of apical sodium-dependent bile acid transporter changes bile composition and blocks progression of sclerosing cholangitis in multidrug resistance 2 knockout mice
- (2015) Alexander G. Miethke et al. HEPATOLOGY
- Enhanced liver fibrosis score predicts transplant-free survival in primary sclerosing cholangitis
- (2015) Mette Vesterhus et al. HEPATOLOGY
- Surrogate endpoints for clinical trials in primary sclerosing cholangitis: Review and results from an International PSC Study Group consensus process
- (2015) Cyriel Y. Ponsioen et al. HEPATOLOGY
- Prospective study of bezafibrate for the treatment of primary sclerosing cholangitis
- (2015) Suguru Mizuno et al. Journal of Hepato-Biliary-Pancreatic Sciences
- O080 : Early clinical features associated with long-term risk of transplantation in primary sclerosing cholangitis: Results from the UK-PSC consortium
- (2015) E.C. Goode et al. JOURNAL OF HEPATOLOGY
- Applicability and prognostic value of histologic scoring systems in primary sclerosing cholangitis
- (2015) Elisabeth M.G. de Vries et al. JOURNAL OF HEPATOLOGY
- 24-nor-ursodeoxycholic acid ameliorates inflammatory response and liver fibrosis in a murine model of hepatic schistosomiasis
- (2015) Martina Sombetzki et al. JOURNAL OF HEPATOLOGY
- EASL Clinical Practice Guidelines: Autoimmune hepatitis
- (2015) JOURNAL OF HEPATOLOGY
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- Liver transplantation in the Nordic countries – An intention to treat and post-transplant analysis from The Nordic Liver Transplant Registry 1982–2013
- (2015) Bjarte Fosby et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells
- (2015) Mohamed-Sami Trabelsi et al. Nature Communications
- The human gut sterolbiome: bile acid-microbiome endocrine aspects and therapeutics
- (2015) Jason M. Ridlon et al. Acta Pharmaceutica Sinica B
- Tu1002 Fenofibrate Improves Alkaline Phosphatase in Primary Sclerosing Cholangitis
- (2015) Adriana Dejman et al. GASTROENTEROLOGY
- Reduction in alkaline phosphatase is associated with longer survival in primary sclerosing cholangitis, independent of dominant stenosis
- (2014) C. Rupp et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Baseline Values and Changes in Liver Stiffness Measured by Transient Elastography Are Associated With Severity of Fibrosis and Outcomes of Patients With Primary Sclerosing Cholangitis
- (2014) Christophe Corpechot et al. GASTROENTEROLOGY
- Serum metabolic signatures of primary biliary cirrhosis and primary sclerosing cholangitis
- (2014) Lauren N Bell et al. LIVER INTERNATIONAL
- Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications - a review
- (2014) Bogna Grygiel-Górniak Nutrition Journal
- Review article: controversies in the management of primary biliary cirrhosis and primary sclerosing cholangitis
- (2013) T. H. Karlsen et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis - a pilot study
- (2013) J. H. Tabibian et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Minocycline: far beyond an antibiotic
- (2013) N Garrido-Mesa et al. BRITISH JOURNAL OF PHARMACOLOGY
- Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR Antagonist
- (2013) Sama I. Sayin et al. Cell Metabolism
- Association Between Reduced Levels of Alkaline Phosphatase and Survival Times of Patients With Primary Sclerosing Cholangitis
- (2013) Lina Lindström et al. Clinical Gastroenterology and Hepatology
- Nuclear Receptors as Drug Targets in Cholestatic Liver Diseases
- (2013) Emina Halilbasic et al. Clinics in Liver Disease
- Mucosal Addressin Cell Adhesion Molecule (MAdCAM-1) Expression Is Upregulated in the Cirrhotic Liver and Immunolocalises to the Peribiliary Plexus and Lymphoid Aggregates
- (2013) Aftab Ala et al. DIGESTIVE DISEASES AND SCIENCES
- Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis
- (2013) Kirsten Boonstra et al. HEPATOLOGY
- Radiologic course of primary sclerosing cholangitis: Assessment by three-dimensional magnetic resonance cholangiography and predictive features of progression
- (2013) Ana Ruiz et al. HEPATOLOGY
- Peroxisome proliferator-activated receptor α activates human multidrug resistance transporter 3/ATP-binding cassette protein subfamily B4 transcription and increases rat biliary phosphatidylcholine secretion
- (2013) Nisanne S. Ghonem et al. HEPATOLOGY
- Mucosal immunity in liver autoimmunity: A comprehensive review
- (2013) Palak J. Trivedi et al. JOURNAL OF AUTOIMMUNITY
- Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis
- (2013) Jimmy Z Liu et al. NATURE GENETICS
- Bile acid receptors as targets for drug development
- (2013) Frank G. Schaap et al. Nature Reviews Gastroenterology & Hepatology
- Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
- (2013) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
- (2013) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology
- (2013) Ingmar Mederacke et al. Nature Communications
- Role of the Microbiota and Antibiotics in Primary Sclerosing Cholangitis
- (2013) James H. Tabibian et al. Biomed Research International
- High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia
- (2012) L. Lindström et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Anticholestatic effects of bezafibrate in patients with primary biliary cirrhosis treated with ursodeoxycholic acid
- (2012) Akira Honda et al. HEPATOLOGY
- Genome-wide association analysis in Primary sclerosing cholangitis and ulcerative colitis identifies risk loci atGPR35andTCF4
- (2012) David Ellinghaus et al. HEPATOLOGY
- Immunomodulatory Effect of Vancomycin on Treg in Pediatric Inflammatory Bowel Disease and Primary Sclerosing Cholangitis
- (2012) David N. Abarbanel et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci
- (2012) Trine Folseraas et al. JOURNAL OF HEPATOLOGY
- Improvement of serum alkaline phosphatase to
- (2012) Said Al Mamari et al. JOURNAL OF HEPATOLOGY
- Recurrence and rejection in liver transplantation for primary sclerosing cholangitis
- (2012) Bjarte Fosby WORLD JOURNAL OF GASTROENTEROLOGY
- Urosdeoxycholic acid in primary sclerosing cholangitis: A meta-analysis and systematic review
- (2012) Mohamed O. Othman et al. Arab Journal of Gastroenterology
- Meta-analysis: ursodeoxycholic acid for primary sclerosing cholangitis
- (2011) C. K. Triantos et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis
- (2011) M. H. Imam et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- High-Dose Ursodeoxycholic Acid Is Associated With the Development of Colorectal Neoplasia in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis
- (2011) John E Eaton et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Alkaline phosphatase normalization is associated with better prognosis in primary sclerosing cholangitis
- (2011) Peter P. Stanich et al. DIGESTIVE AND LIVER DISEASE
- What an endoscopist should know about immunoglobulin-G4-associated disease of the pancreas and biliary tree
- (2011) L. Maillette de Buy Wenniger et al. ENDOSCOPY
- FXR activation inhibits inflammation and preserves the intestinal barrier in IBD
- (2011) M. E. Wildenberg et al. GUT
- A biliary HCO3−umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes
- (2011) Simon Hohenester et al. HEPATOLOGY
- Update on primary sclerosing cholangitis
- (2010) Tom H. Karlsen et al. DIGESTIVE AND LIVER DISEASE
- Nor-ursodeoxycholic acid reverses hepatocyte-specific nemo-dependent steatohepatitis
- (2010) N. Beraza et al. GUT
- Combination of retinoic acid and ursodeoxycholic acid attenuates liver injury in bile duct-ligated rats and human hepatic cells
- (2010) Hongwei He et al. HEPATOLOGY
- Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression
- (2010) Emmanouil Sinakos et al. HEPATOLOGY
- Regulation of mucosal addressin cell adhesion molecule 1 expression in human and mice by vascular adhesion protein 1 amine oxidase activity
- (2010) Evaggelia Liaskou et al. HEPATOLOGY
- Bezafibrate for the treatment of primary sclerosing cholangitis
- (2010) Suguru Mizuno et al. JOURNAL OF GASTROENTEROLOGY
- Overlap syndromes: The International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue
- (2010) Kirsten Muri Boberg et al. JOURNAL OF HEPATOLOGY
- Retinoic acid represses CYP7A1 expression in human hepatocytes and HepG2 cells by FXR/RXR-dependent and independent mechanisms
- (2010) Shi-Ying Cai et al. JOURNAL OF LIPID RESEARCH
- Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci
- (2010) Espen Melum et al. NATURE GENETICS
- Genome-Wide Association Analysis in Primary Sclerosing Cholangitis
- (2009) Tom H. Karlsen et al. GASTROENTEROLOGY
- p-ANCAs in autoimmune liver disorders recognise human -tubulin isotype 5 and cross-react with microbial protein FtsZ
- (2009) B. Terjung et al. GUT
- Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2−/− mice
- (2009) Emina Halilbasic et al. HEPATOLOGY
- Portal fibroblasts: Underappreciated mediators of biliary fibrosis
- (2009) Jonathan A. Dranoff et al. HEPATOLOGY
- Diagnosis and management of primary sclerosing cholangitis
- (2009) Roger Chapman et al. HEPATOLOGY
- High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis
- (2009) Keith D. Lindor et al. HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of cholestatic liver diseases
- (2009) JOURNAL OF HEPATOLOGY
- Long-term Treatment of Primary Sclerosing Cholangitis in Children With Oral Vancomycin: An Immunomodulating Antibiotic
- (2009) Yinka K Davies et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Minocycline in the Treatment of Patients With Primary Sclerosing Cholangitis: Results of a Pilot Study
- (2008) Marina G Silveira et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Probiotics in primary sclerosing cholangitis: a randomized placebo-controlled crossover pilot study
- (2008) Frank P. Vleggaar et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- A Double-blind, Placebo-controlled, Randomized Study of Infliximab in Primary Sclerosing Cholangitis
- (2008) Daan W. Hommes et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis
- (2008) Marina G. Silveira et al. JOURNAL OF HEPATOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started